Koneksa

📍 New York, United States🗓 Founded 2015👥 107 employees💰 Last funded Feb 2022
Pharmaceutical Manufacturing🌐 koneksahealth.com
Website LinkedIn
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Switzerland
1
Frequently asked questions
Who invested in Koneksa?
Koneksa has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Koneksa last raise funding?
The most recent investment in Koneksa recorded on gritt.io was in February 2022.
When was Koneksa founded?
Koneksa was founded in 2015.
What industry is Koneksa in?
Koneksa operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Koneksa based?
Koneksa is headquartered in New York, United States.